-
(单词翻译:双击或拖选)
These two omicron subvariants could be the source of another COVID surge
Two subvariants that have emerged from the soup of Omicron offspring are among the most adept3 at evading4 immunity5. They appear poised6 to become dominant7 in the U.S. and could fuel a new surge.
STEVE INSKEEP, HOST:
Pandemic still isn't over. Two omicron subvariants have new ways to get around our immune systems and are poised to become dominant in the United States, according to the Centers for Disease Control and Prevention. NPR health correspondent Rob Stein is covering the story. Rob, good morning.
ROB STEIN, BYLINE8: Good morning, Steve.
INSKEEP: What is the news here of these subvariants?
STEIN: You know, Steve, scientists have been watching a swarm9 of even more transmissible subvariants that have been emerging as omicron has dominated the pandemic and evolved over the past year. And two of them have been gaining ground in the U.S. over the last few weeks called BQ.1 BQ.1.1. Here's Dr. Jeremy Luban at the University of Massachusetts.
JEREMY LUBAN: It's a little bit eerily10 familiar this time of year. Last year, we were similarly optimistic. We were coming out of the delta11 wave, and it was steadily12 decreasing. And we went into Thanksgiving to wake up to omicron. So there is this sort of deja vu feeling from last year.
STEIN: Because like the original omicron, these two new subvariants have found even more ways to sneak13 around our immune systems.
INSKEEP: I guess this is inevitable14. It's evolution. People get sick and get some immunity, or they get vaccinated15 and get some immunity. And then the variations of the virus that get around that then are able to spread. So how much better are these variants1?
STEIN: Yeah, absolutely. You know, new mutations in the virus's spike16 protein appear to make them maybe 2 to 7 times more immune-evasive than the BA.5 omicron subvariant that's been dominating the pandemic since the summer. I talked about this with Dr. Daniel Barouch, who's been studying the new viruses in his lab at Harvard.
DANIEL BAROUCH: The bad news is that it's likely that people who've been vaccinated and/or infected will still get infected. But fortunately, vaccine17 immunity and natural immunity will likely still be effective at preventing severe disease. And that's the most important thing. So it's a cause for concern but not a cause for alarm.
STEIN: Because even though these new subverts18 could infect more people, they don't appear to make people sicker than the previous variants.
INSKEEP: But could they lead to a winter surge?
STEIN: Well, you know, they certainly won't help. I talked about this with Samuel Scarpino from The Rockefeller Foundation.
SAMUEL SCARPINO: Both of these variants are associated with an increase in cases in the U.S. So the question is whether this increase is going to be nationwide and whether the size of the increase and the surge will be something like what we experienced with delta and omicron or much smaller.
STEIN: And possibly much shorter. I asked White House adviser19 Dr. Anthony Fauci about this. He doubts any new surge will get anywhere near as bad as last winter's.
ANTHONY FAUCI: We are hoping that the amount of immunity that has been induced either by prior infection or by vaccination20 - and hopefully, more people will go and get their updated vaccine, the bivalent vaccine - that that would mitigate21 a real surge and at worst will get a blip versus22 a major surge.
STEIN: You know, while some preliminary studies have questioned whether the new boosters are any better than the original vaccine at protecting against omicron, Fauci says the jury's still out about that. And in fact, Pfizer and BioNTech released a statement today saying a study involving 900 volunteers shows their new booster stimulates23 much higher levels of antibodies that could neutralize24 the Ba.5 omicron subvariant than the original vaccine. But another worry is these new subvariants are likely to render the last monoclonal antibody drugs useless. And even just a blip of a COVID resurgence25 could strain hospitals also struggling with the flu and RSV.
INSKEEP: Rob, thanks so much.
STEIN: You bet, Steve.
INSKEEP: NPR health correspondent Rob Stein.
1 variants | |
n.变体( variant的名词复数 );变种;变型;(词等的)变体 | |
参考例句: |
|
|
2 transcript | |
n.抄本,誊本,副本,肄业证书 | |
参考例句: |
|
|
3 adept | |
adj.老练的,精通的 | |
参考例句: |
|
|
4 evading | |
逃避( evade的现在分词 ); 避开; 回避; 想不出 | |
参考例句: |
|
|
5 immunity | |
n.优惠;免除;豁免,豁免权 | |
参考例句: |
|
|
6 poised | |
a.摆好姿势不动的 | |
参考例句: |
|
|
7 dominant | |
adj.支配的,统治的;占优势的;显性的;n.主因,要素,主要的人(或物);显性基因 | |
参考例句: |
|
|
8 byline | |
n.署名;v.署名 | |
参考例句: |
|
|
9 swarm | |
n.(昆虫)等一大群;vi.成群飞舞;蜂拥而入 | |
参考例句: |
|
|
10 eerily | |
adv.引起神秘感或害怕地 | |
参考例句: |
|
|
11 delta | |
n.(流的)角洲 | |
参考例句: |
|
|
12 steadily | |
adv.稳定地;不变地;持续地 | |
参考例句: |
|
|
13 sneak | |
vt.潜行(隐藏,填石缝);偷偷摸摸做;n.潜行;adj.暗中进行 | |
参考例句: |
|
|
14 inevitable | |
adj.不可避免的,必然发生的 | |
参考例句: |
|
|
15 vaccinated | |
[医]已接种的,种痘的,接种过疫菌的 | |
参考例句: |
|
|
16 spike | |
n.长钉,钉鞋;v.以大钉钉牢,使...失效 | |
参考例句: |
|
|
17 vaccine | |
n.牛痘苗,疫苗;adj.牛痘的,疫苗的 | |
参考例句: |
|
|
18 subverts | |
v.颠覆,破坏(政治制度、宗教信仰等)( subvert的第三人称单数 );使(某人)道德败坏或不忠 | |
参考例句: |
|
|
19 adviser | |
n.劝告者,顾问 | |
参考例句: |
|
|
20 vaccination | |
n.接种疫苗,种痘 | |
参考例句: |
|
|
21 mitigate | |
vt.(使)减轻,(使)缓和 | |
参考例句: |
|
|
22 versus | |
prep.以…为对手,对;与…相比之下 | |
参考例句: |
|
|
23 stimulates | |
v.刺激( stimulate的第三人称单数 );激励;使兴奋;起兴奋作用,起刺激作用,起促进作用 | |
参考例句: |
|
|
24 neutralize | |
v.使失效、抵消,使中和 | |
参考例句: |
|
|
25 resurgence | |
n.再起,复活,再现 | |
参考例句: |
|
|